About Agnus
Agnus is a company based in Bengaluru (India) founded in 2002. Limited information available. It operates on a B2B model. Its Indian entity Agnus Pharmaceuticals Private Limited reported revenue of ₹91.7 Lakh.
Company details
Agnus in Bengaluru, India. Limited information available The company is dedicated to excellence, innovation, and customer satisfaction in its operations. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
- Headquarters Bengaluru, India
- Website agnus.in
- Legal Name Agnus Pharmaceuticals Private Limited
- Date of Incorporation 13 May, 2009
- Jurisdiction Kozhikode, Kerala, India
- Annual Revenue₹91.7 Lakh
FY 2026 · +6% YoY
- Net Profit₹85,727
FY 2026 · 1% margin
- EBITDA₹1.2 Lakh
FY 2026 · 1% margin
Associated legal entities of Agnus
Agnus operates through Agnus Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Agnus Pharmaceuticals Private Limited CIN U24230KL2009PTC024164 | Active | 13 May 2009 | Kozhikode, Kerala | ₹0.9 Cr | 2 | View details |
Board of directors of Agnus Pharmaceuticals Private Limited (Agnus)
Agnus Pharmaceuticals Private Limited is the primary company behind Agnus. The board of Agnus Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Koothanil Narayanan Murali, appointed in 2009.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Koothanil Narayanan Murali DIN 02564792 | Director | 13 May 2009 | 17 yrs 6 mo | Agnus Pharmaceuticals Private Limited |
| Gokul Das Chedempath DIN 02564766 | Managing Director | 13 May 2009 | 17 yrs 6 mo | Agnus Pharmaceuticals Private Limited |
Financials of Agnus
Figures of Agnus Pharmaceuticals Private Limited, the primary company behind Agnus, for FY 2026. Revenue was ₹91.7 Lakh (+6% year on year). Net profit was ₹85,727 (1% margin). EBITDA was ₹1.2 Lakh (1% margin). Revenue has grown at a compounded annual rate of +4% over three years and +14% over five years.
- ₹91.7 LakhRevenue · FY 2026 · +6% YoY
- ₹85,727Net profit · 1% margin
- ₹1.2 LakhEBITDA · 1% margin
- ₹1 LakhPaid-up capital
- +4%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Agnus Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Agnus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Agnus
Agnus was founded in 2002.
Agnus is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Agnus, Agnus Pharmaceuticals Private Limited, reported revenue of ₹91.7 Lakh for FY 2026, up 6% year on year.
Agnus in Bengaluru, India. Limited information available The company is dedicated to excellence, innovation, and customer satisfaction in its operations. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
Agnus operates through Agnus Pharmaceuticals Private Limited.
The legal entities of Agnus currently have 2 directors, including Koothanil Narayanan Murali, Gokul Das Chedempath.